Abstract
It is shown that sodium hydroxybutyrate exerts a preventive and therapeutic effect on models of neuropathic pain syndrome and adjuvant arthritis. The effects of sodium hydroxybutyrate droxybutyrate are correlated with its ability to reduce hyperactivity of the neurons that are generators of pathologically enhanced excitation and to inhibit the pathological algetic system.
Similar content being viewed by others
References
N. A. Kruglov and R. I. Kvasnoi, in:Sodium Hydroxybutyrate: Neuropharmacology and Clinical Studies [in Russian], Moscow (1968), pp. 5–18.
G. N. Kryzhanovskii,Determinant Structures in Nervous System Pathology [in Russian], Moscow (1980).
V. K. Reshetnyak and M. L. Kukushkin,Byull. Eksp. Biol. Med.,102, No. 11, 517–519 (1986).
A. S. Saratikov, L. L. Fisanova, T. A. Zamoshchina,et al., —Ibid.,101, No. 3, 312–315.
E. B. Khaisman, L. A. Malikova, V. A. Arefolov, —Ibid.,100, No. 9, 317–319 (1985).
V. V. Churyukanov,in: Sodium Hydroxybutyrate: Neuropharmacology and Clinical Studies [in Russian], Moscow (1968), pp. 19–25.
S. Armez and B. A. Meyerson,Pain,33, 11–23 (1988).
M. J. Calado, J. Del Rio, and E. Peralta, —Ibid.,56, 3–8 (1994).
G. Guilbaud, A. Levante, and I. Benoist, —Ibid., Suppl. 5, 277 (1990).
V. Hechler, S. Gobaille, J. J. Bourguiguon,et al., J. Neurochem.,56, 938–942 (1991).
M. Mamelok,Neurosci. Biobehav. Rev.,13, No. 4, 187–198 (1989).
J. Neil-Fugazza, F. Codefroy, V. Manceau,et al., Brain Res.,374, 190–194 (1986).
C. Schmidt, S. Gobaile, V. Hechler,et al., Eur. J. Pharmacol.,203, 393–397 (1991).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 121, No. 4, pp. 395–398, April, 1996
Rights and permissions
About this article
Cite this article
Danilova, E.I., Grafova, V.N., Ostrovskaya, R.U. et al. Effect of sodium hydroxybutyrate in pain syndromes. Bull Exp Biol Med 121, 359–362 (1996). https://doi.org/10.1007/BF02446727
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02446727